Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for JMI Syringes & Medical Devices's Debt-to-Equity or its related term are showing as below:
DHA:JMISMDL's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.24 * Ranked among companies with meaningful Debt-to-Equity only.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
JMI Syringes & Medical Devices Debt-to-Equity Related Terms
JMI Syringes & Medical Devices Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMI Syringes & Medical Devices Debt-to-Equity Chart
DHA:JMISMDL vs ISRG, BDX, MDLN: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, JMI Syringes & Medical Devices's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMI Syringes & Medical Devices Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMI Syringes & Medical Devices's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where JMI Syringes & Medical Devices's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMI Syringes & Medical Devices (DHA:JMISMDL) has a Debt-to-Equity of 0.02 as of Mar. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on JMI Syringes & Medical Devices and its competitors.
Is JMI Syringes & Medical Devices' Debt-to-Equity too high?
JMI Syringes & Medical Devices' current Debt-to-Equity is 0.02. The Medical Devices & Instruments industry median Debt-to-Equity is 0.24. JMI Syringes & Medical Devices' value of 0.02 is 91.7% below this industry median. Overall, JMI Syringes & Medical Devices has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does JMI Syringes & Medical Devices' Debt-to-Equity compare to ISRG and BDX?
JMI Syringes & Medical Devices' Debt-to-Equity of 0.02 can be compared against companies in the Medical Devices & Instruments industry. The industry median Debt-to-Equity is 0.24. JMI Syringes & Medical Devices' value of 0.02 is 91.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.24, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMI Syringes & Medical Devices's current Debt-to-Equity of 0.02 is 91.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on JMI Syringes & Medical Devices and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMI Syringes & Medical Devices's current Debt-to-Equity is 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Syringes & Medical Devices stock overvalued right now?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a current Debt-to-Equity of 0.02. The current Debt-to-Equity is 0.02 and 91.7% below the Medical Devices & Instruments industry median of 0.24. JMI Syringes & Medical Devices' overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For JMI Syringes & Medical Devices (DHA:JMISMDL), the current Debt-to-Equity is 0.02 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.
75GF Score
Get the complete analysis for DHA:JMISMDL
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:JMISMDL has been successfully added to your 
